Celldex Therapeutics, Inc.
CLDXNASDAQHealthcare● Active
$28.56
$-0.06(-0.21%)
Market Cap$1.9B
P/E Ratio—
52W High$35.79
52W Low$19.52
Celldex Therapeutics, Inc. (CLDX) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CLDX · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $518.57M | $725.28M | $421.70M | $304.95M | $408.25M |
| Net Receivables | $2.02M | $0.70M | $4.53M | $0.35M | $0.17M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $534.66M | $747.16M | $431.69M | $317.69M | $410.84M |
| PP&E Net | $7.77M | $8.24M | $6.64M | $7.75M | $6.52M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $27.19M | $27.19M | $27.19M | $27.19M | $27.19M |
| Total Assets | $582.98M | $792.34M | $465.63M | $352.74M | $444.65M |
| Liabilities | |||||
| Short-Term Debt | $1.55M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $1.18M | $3.27M | $3.49M | $3.34M | $1.23M |
| Total Current Liabilities | $50.99M | $39.50M | $31.13M | $18.61M | $16.53M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $55.82M | $45.34M | $36.46M | $26.53M | $25.18M |
| Stockholders Equity | |||||
| Retained Earnings | ($1813.98M) | ($1555.22M) | ($1397.36M) | ($1255.93M) | ($1143.61M) |
| Total Stockholders Equity | $527.16M | $747.00M | $429.17M | $326.20M | $419.48M |
| Total Liab & Equity(computed) | $582.98M | $792.34M | $465.63M | $352.74M | $444.65M |
| Debt Summary | |||||
| Total Debt | $2.34M | $3.81M | $2.54M | $4.03M | $3.04M |
| Net Debt | ($26.54M) | ($24.54M) | ($32.27M) | ($25.40M) | ($36.10M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Celldex Therapeutics, Inc. data
About Celldex Therapeutics, Inc. (CLDX) Balance Sheet
Celldex Therapeutics, Inc. (CLDX) balance sheet shows total assets of $0.58B with cash of $0.52B. Total liabilities are $0.06B, total debt $0.00B, and stockholders equity $0.53B.
Frequently asked questions
CLDX · 4 questionsCelldex Therapeutics, Inc. has total debt of $0.00B with net debt of ($0.03B).
CLDX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10